SCHEMBL24676701

SCHEMBL24676701

CN(C)Cc1nc(C(F)(F)F)c(-c2cc(NC3CCN(S(C)(=O)=O)CC3)ncc2F)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.42
CDK2 P24941 13/20 0.40
CCNE1 P24864 12/20 0.40
CCND1 P24385 7/20 0.40
CDK6 Q00534 7/20 0.40
TDO2 P48775 1/20 0.40
RORC P51449 1/20 0.39
CDK1 P06493 3/20 0.39
CCNB1 P14635 3/20 0.39
CCNB2 O95067 1/20 0.39
CCNE2 O96020 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
CDK4 P11802 4/20 0.39
CCND3 P30281 4/20 0.39
IDO1 P14902 1/20 0.37
CCNT1 O60563 1/20 0.37
PTK2 Q05397 1/20 0.37
CXCR3 P49682 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29754809 1.00 GPR119 (0.42) GPR119CDK2CCNE1CCND1CDK6
SCHEMBL24676472 0.90 TDO2 (0.42) GPR119CDK2CCNE1CCND1CDK6
SCHEMBL24676694 0.89 CDK2 (0.42) GPR119CDK2CCNE1CCND1CDK6
SCHEMBL24676702 0.88 GPR119 (0.40) GPR119CDK2CCNE1CCND1CDK6
SCHEMBL24676665 0.85 GPR119 (0.40) GPR119CDK2CCNE1CCND1CDK6
SCHEMBL24676950 0.84 TDO2 (0.42) GPR119CDK2CCNE1CCND1CDK6
SCHEMBL24676765 0.84 CDK2 (0.54) CDK2CCNE1CCND1CDK6CDK1
SCHEMBL29754806 0.84 CDK2 (0.54) CDK2CCNE1CCND1CDK6CDK1
SCHEMBL24676824 0.84 TDO2 (0.43) GPR119CDK2CCNE1CCND1CDK6
SCHEMBL24676002 0.84 CDK2 (0.49) GPR119CDK2CCNE1CCND1CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022155941-A1 CDK2 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-07-28 WO disclosed